RECURRENT NEUROBLASTOMA
Clinical trials for RECURRENT NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancer: major trial tests antibody cocktail
Disease control CompletedThis large, completed Phase 3 trial tested whether adding a combination of immunotherapy drugs to standard chemotherapy improved outcomes for children with high-risk neuroblastoma. The study involved 1,449 young patients who had already undergone intensive treatment, including a …
Matched conditions: RECURRENT NEUROBLASTOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Drug attack tested for tough childhood cancers
Disease control CompletedThis early-phase study tested the safety and best dose of two antibody drugs, magrolimab and dinutuximab, given together to children and young adults whose neuroblastoma or osteosarcoma had come back or stopped responding to other treatments. The main goal was to see if the combi…
Matched conditions: RECURRENT NEUROBLASTOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC